Evaluation of myocardial perfusion and left ventricular function six months after percutaneous transmyocardial laser revascularization: Comparison of two Ho-YAG laser systems with the same wavelength, but different energy delivery and navigation systems
✍ Scribed by Christoph Strehblow; Mariann Gyöngyösi; Aliasghar Khorsand; Wolfgang Sperker; Melanie Gatterer; Senta Graf; Heinz Sochor; Dietmar Glogar
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 210 KB
- Volume
- 33
- Category
- Article
- ISSN
- 0196-8092
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background and Objectives
Myocardial perfusion and left ventricular function (LVF) were assessed after percutaneous transmyocardial laser revascularization (PTMR) in patients not amenable to conventional revascularization, with a comparison of two laser systems.
Study Design/Materials and Methods
PTMR was performed with an Eclipse laser in 15 patients, and with a Biosense DMR in 10 patients. ^201^Thallium scintigraphy, coronary angiography, and ventriculography were performed at baseline and at the 7.5±4.3‐month follow‐up. All patients in the Biosense DMR group and 10 in the Eclipse group underwent NOGA mapping before PTMR and after follow‐up.
Results
The event‐free survival rates were comparable, and the angina scores of all patients improved significantly, but more so in the Biosense DMR group than in the Eclipse group (1.2±1.1 vs. 2.3±0.9, P < 0.05). Both, the electrical activity assessed by NOGA mapping and the normalized ^201^thallium uptake at redistribution improved significantly in the treated segments after Biosense DMR, while the global LVF decreased insignificantly in the Eclipse group.
Conclusions
PTMR resulted in significant improvements in the clinical symptoms, but the electrical activity improved only in the Biosense DMR group, without transforming to a better LVF. Lasers Surg. Med. 33:273–281, 2003. © 2003 Wiley‐Liss, Inc.